Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study.

BACKGROUND Coffee is one of the most widely consumed beverages worldwide and has been of considerable interest in research on cognition and dementia. OBJECTIVE To investigate the effect of coffee on preclinical brain MRI markers of dementia and cognitive performance. METHODS In 2,914 participants from the population-based Rotterdam Study (mean age: 59.3±7.2 years, 55% females), we assessed coffee consumption, performed brain MRI, and assessed cognition at baseline. To study cognitive change, cognitive assessment was repeated after 5 years of follow-up. Coffee consumption was analyzed continuously (per cup increase) and in categories (0-1, >1-3, >3 cups/day). Using logistic and linear regression, associations of coffee consumption with lacunar infarcts and brain tissue volumes on MRI, and cognitive performance (cross-sectional and longitudinal) were investigated, adjusting for relevant confounders. RESULTS We found that higher coffee consumption was associated with a lower prevalence of lacunar infarcts [odds ratio per cup increase: 0.88 (95% CI:0.79;0.98)], and smaller hippocampal volume [difference: -0.01 (95% CI:-0.02;0.00)]. Also, we found that the highest category of coffee consumption was associated with better performance on the Letter Digit Substitution Task [difference: 1.13(95% CI:0.39;1.88)], Word Fluency test [0.74(95% CI:0.04,1.45)], Stroop interference task [1.82(95% CI:0.23;3.41)], and worse performance on the 15-Word Learning test delayed recall [-0.38(95% CI:-0.74;-0.02)]. These associations were not found when cognition was analyzed longitudinally. CONCLUSION We found complex associations between coffee consumption, brain structure, and cognition. Higher coffee consumption was cross-sectionally associated with a lower occurrence of lacunar infarcts and better executive function, but also with smaller hippocampal volume and worse memory function.

[1]  A. Hofman,et al.  The Rotterdam Scan Study: design update 2016 and main findings , 2015, European Journal of Epidemiology.

[2]  S. Chrysant Coffee Consumption and Cardiovascular Health. , 2015, The American journal of cardiology.

[3]  S. Vittori,et al.  The influence of different types of preparation (espresso and brew) on coffee aroma and main bioactive constituents , 2015, International journal of food sciences and nutrition.

[4]  M. Inoue,et al.  Association of coffee intake with total and cause-specific mortality in a Japanese population: the Japan Public Health Center-based Prospective Study. , 2015, The American journal of clinical nutrition.

[5]  O. Franco,et al.  Coffee consumption and incident dementia , 2014, European Journal of Epidemiology.

[6]  Aad van der Lugt,et al.  Patterns of cognitive function in aging: the Rotterdam Study , 2014, European Journal of Epidemiology.

[7]  H. Fillit,et al.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease , 2014, The journal of nutrition, health & aging.

[8]  F. Hu,et al.  Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies , 2014, Circulation.

[9]  F. Hu,et al.  Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis , 2014, Diabetes Care.

[10]  C. Vecchia,et al.  A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases , 2013, European Journal of Epidemiology.

[11]  C. Berr,et al.  Caffeine and cognitive decline in elderly women at high vascular risk. , 2013, Journal of Alzheimer's disease : JAD.

[12]  L. Arab,et al.  Epidemiologic Evidence of a Relationship between Tea , Coffee , or Caffeine Consumption and Cognitive Decline 1 , 2 , 2012 .

[13]  B. Shukitt-Hale,et al.  Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging , 2013, AGE.

[14]  R. Sinha,et al.  Association of coffee drinking with total and cause-specific mortality. , 2012, The New England journal of medicine.

[15]  G. J. Klapstein,et al.  The role of inflammatory processes in Alzheimer’s disease , 2012, Inflammopharmacology.

[16]  P. Agostinho,et al.  Caffeine Consumption Prevents Diabetes-Induced Memory Impairment and Synaptotoxicity in the Hippocampus of NONcZNO10/LTJ Mice , 2012, PloS one.

[17]  C. Scaccini,et al.  Role of coffee in modulation of diabetes risk. , 2012, Nutrition reviews.

[18]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[19]  M. Moraes,et al.  Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains , 2011, Pharmacology Biochemistry and Behavior.

[20]  I. Janszky,et al.  Coffee consumption may influence hippocampal volume in young women , 2011, Brain Imaging and Behavior.

[21]  L. White,et al.  Coffee intake in midlife and risk of dementia and its neuropathologic correlates. , 2011, Journal of Alzheimer's disease : JAD.

[22]  L. Arab,et al.  Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study. , 2011, Journal of Alzheimer's disease : JAD.

[23]  N. Lunet,et al.  Caffeine intake and dementia: systematic review and meta-analysis. , 2010, Journal of Alzheimer's disease : JAD.

[24]  R. Cunha,et al.  Caffeine, adenosine receptors, and synaptic plasticity. , 2010, Journal of Alzheimer's disease : JAD.

[25]  Ana M Sebastião,et al.  Caffeine and adenosine. , 2010, Journal of Alzheimer's disease : JAD.

[26]  Peter H. Brown,et al.  Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. , 2009, Journal of agricultural and food chemistry.

[27]  Wiro J. Niessen,et al.  White matter lesion extension to automatic brain tissue segmentation on MRI , 2009, NeuroImage.

[28]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[29]  Wiro J. Niessen,et al.  Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts , 2008, NeuroImage.

[30]  P. Barberger‐Gateau,et al.  The neuroprotective effects of caffeine , 2007, Neurology.

[31]  Wiro J. Niessen,et al.  Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification , 2007, NeuroImage.

[32]  Aad van der Lugt,et al.  O3-04-07 Prevalence and risk factors of cerebral microbleeds in the Rotterdam scan study , 2006, Alzheimer's & Dementia.

[33]  L. Andersen,et al.  Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. , 2006, The American journal of clinical nutrition.

[34]  J. Whitworth,et al.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.

[35]  D. Altman,et al.  Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.

[36]  C. Tanner,et al.  Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.

[37]  B. Shukitt-Hale The effects of aging and oxidative stress on psychomotor and cognitive behavior , 1999, AGE.

[38]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[39]  A Hofman,et al.  Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire , 1998, European Journal of Clinical Nutrition.

[40]  C. Clark,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1990, Neurology.

[41]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[42]  J. Jolles,et al.  Stroop interference: aging effects assessed with the Stroop Color-Word Test. , 1993, Experimental aging research.

[43]  J Agnew,et al.  Age-related sex differences in verbal memory. , 1988, Journal of clinical psychology.

[44]  L. Radloff The CES-D Scale , 1977 .

[45]  J. Tiffin,et al.  The Purdue pegboard; norms and studies of reliability and validity. , 1948, The Journal of applied psychology.